Connective tissue growth factor is an indicator of bone involvement in multiple myeloma, but matrix metalloproteinase-9 is not

British Journal of Haematology

Volumn 139, Issue 1, 2007, Pages 41-50

  Munemasa, Shoso ^a   Sakai, Akira ^a   Kuroda, Yoshiaki ^a   Okikawa, Yoshiko ^a   Katayama, Yuta ^b   Asaoku, Hideki ^b   Kubo, Tadahiko ^c   Miyakawa, Yoshitaka ^d   Serikawa, Masahiro ^c   Sasaki, Tamito ^c   Kimura, Akiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d KEIO UNIVERSITY   (Japan)

Author keywords

Bone disease; Bone marrow; Connective tissue growth factor; Matrix metalloproteinase; Multiple myeloma

Indexed keywords

BIOLOGICAL MARKER; CONNECTIVE TISSUE GROWTH FACTOR; GELATINASE B; PROTEINASE;

ADULT; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VENOUS BLOOD;

AGED; BONE MARROW; CASE-CONTROL STUDIES; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOMA; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MULTIPLE MYELOMA; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 34548580623     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06721.x     Document Type: Article

References (33)

1. Abreu, J.G., Ketpura, N.I., Reversade, B. Robertis, E.M. (2002) Connective-tissue growth factor (CTGF) modulates cell signaling by BMP and TGF-β. Nature Cell Biology, 4, 599 604.
2. Alexandrakis, M., Sfiridaki, A., Miyakis, S., Pappa, C., Kandidaki, E., Alegakis, A. Margioris, A.N. (2007) Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma. Clinica Chemica Acta, 379, 31 35.
3. Barille, S., Akhoundi, C., Collette, M., Mellerin, M.P., Rapp, M.J., Harousseau, J.L., Bataille, R. Amiot, M. (1997) Metalloproteinases in multiple myeloma: production of matrix metalloproteinases-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells. Blood, 90, 1649 1655.
4. Barille, S., Bataille, R., Rapp, M.J., Harousseau, J.L. Amiot, M. (1999) Production of metalloproteinases-7 (Matrilysin) by human myeloma cells and its potential involvement in metalloproteinases-2 activation. The Journal of Immunology, 163, 5723 5728.
5. Bradham, D.M., Igarashi, A., Potter, R.L. Grotendorst, G.R. (1991) Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. The Journal of Cell Biology, 114, 1285 1294.
6. Dankbar, B., Padro, T., Leo, R., Feldmann, B., Kropff, M., Mesters, R.M., Serve, H., Berdel, W.E. Kienast, L. (2000) Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. Blood, 95, 2630 2636.
7. Durie, B.G.M. Salmon, S.E. (1975) A clinical staging system for multiple myeloma. Cancer, 36, 842 854.
8. Frazier, K.S. Grotendorst, G.R. (1997) Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors. International Journal of Biochemical Cell Biology, 29, 153 161.
9. Grotendorst, G.R. Duncan, M.R. (2005) Indivisula domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. The Federation of American Societies for Experimental Biology Journal, 19, 729 738.
10. Hashimoto, G., Inoki, I., Fujii, Y., Aoki, T., Ikeda, E. Okada, Y. (2002) Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. The Journal of Biochemical Chemistry, 277, 36288 36295.
11. Hishikawa, K., Oemar, B.S., Tanner, F.C., Nakai, T., Tf, L. Fujii, T. (1999) Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. The Journal of Biological Chemistry, 274, 37461 37466.
12. Hjertner, O., Hjorth-Hansen, H., Borset, M., Seidel, C., Waage, A. Sundan, A. (2001) Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. Blood, 97, 516 522.
13. Inoki, I., Shiomi, T., Hashimoto, G., Enomoto, H., Nakamura, H., Makino, K., Ikeda, E., Takata, S., Kobayashi, K. Okada, Y. (2002) Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. The Federation of American Societies for Experimental Biology Journal, 16, 219 221.
14. Ito, Y., Aten, J., Bende, R.J., Oemar, B.S., Rabelink, T.J., Weening, J.J. Goldschmeding, R. (1998) Expression of connective tissue growth factor in human renal fibrosis. Kidney International, 53, 853 861.
15. Katayama, Y., Sakai, A., Okikawa, Y., Oue, N., Asaoku, A., Imanaka, F., Tsujimoto, T., Takimoto, Y., Masuda, R., Nakaju, N., Otsuki, T., Yasui, W. Kimura, A. (2004) Cyclin D1 overexpression is not a specific grouping marker, but may collaborate with CDC37 in myeloma cells. International Journal of Oncology, 25, 579 595.
16. Kawamura, C., Kizaki, M., Yamato, K., Uchida, H., Fukuchi, Y., Hattori, Y., Koseki, T., Nishihara, T. Ikeda, Y. (2000) Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3. Blood, 96, 2005 2011.
17. Kelly, T., Borset, M., Abe, E., Gaddy-Kurten, D. Sanderson, R.D. (2000) Matrix metalloproteinases in multiple myeloma. Leukemia and Lymphoma, 37, 273 281.
18. Kubo, M., Kikuchi, K., Nashiro, K., Kakinuma, T., Hayashi, N., Nanko, H. Tamaki, K. (1998) Expression of fibrogenic cytokines in desmoplastic malignant melanoma. British Journal of Dermatology, 139, 192 197.
19. Kumar, S., Hand, A.T., Connor, J.R., Dodds, E.A., Ryan, P.J., Trill, J.J., Fisher, S.M., Nuttall, M.E., Lipshutz, D.B., Zou, C., Hwang, S.M., Votta, B.J., James, I.E., Rieman, D.J., Gowen, M. Lee, L.C. (1999) Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions. The Journal of Biological Chemistry, 274, 17123 17131.
20. Luo, Q., Kang, Q., Si, W., Jiang, W., Park, J.K., Peng, Y., Li, X., Luu, H.H., Luo, J., Montag, A.G., Haydon, R.C. He, T.C. (2004) Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteobalst differentiation of mesenchymal stem cell. The Journal of Biochemical Chemistry, 279, 55958 55968.
21. Miyakawa, Y., Ohnishi, Y., Tomisawa, M., Monnai, M., Kohmura, K., Ueyama, Y., Ito, M., Ikeda, Y., Kizaki, M. Nakamura, M. (2003) Establishment of a new model of human multiple myeloma using NOD/SCID/ (NOG) mice. Biochemical and Biophysical Research Communications, 313, 258 262.
22. Nakanishi, T., Kimura, Y., Tamura, T., Ichikawa, H., Yamaai, Y., Sugimoto, T. Takigawa, M. (1997) Cloning of a mRNA preferentially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA. Biochemical and Biophysical Research Communications, 234, 206 210.
23. Nishida, T., Nakanishi, T., Shimo, T., Asano, M., Hattori, T., Tamatani, T., Tezuka, K. Takigawa, M. (1998) Demonstration of receptors specific for connective tissue growth factor on a human chondrocytic cell line (HCS-2/8). Biochemical and Biophysical Research Communications, 247, 905 909.
24. Oshima, T., Abe, M., Asano, J., Hara, T., Kitazoe, K., Sekimoto, E., Shibata, H., Hashimoto, T., Ozaki, S., Kido, S., Inoue, D. Matsumoto, T. (2005) Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2. Blood, 106, 3160 3165.
25. Pereira, R.C., Durant, D. Canalis, E. (2000) Transcriptional regulation of connective tissue growth factor by cortisol in osteoblasts. American Journal of Physiology, Endocrinology and Metabolism, 278, E570 E576.
26. Roestenberg, P., van Nieuwenhoven, F.A., Wieten, L., Boer, P., Diekman, T., Tiller, A.M., Wiersinga, W.M., Oliver, N., Usinger, W., Weitz, S., Schlingemann, R.O. Goldschmeding, R. (2004) Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy. Diabetes Care, 27, 1164 1170.
27. Rosenwald, A., Wright, G., Chan, W.C., Connors, J.M., Campo, E., Fisher, R.I., Gascoyne, R.D., Muller-Hermelink, H.K., Smeland, E.B. Staudt, L.M. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. The New England Journal of Medicine, 346, 1937 1947.
28. Safadi, F.F., Xu, J., Smock, S.L., Kanaa, R.A., Selim, A.H., Odgren, P.R., Marks, Jr., S.C., Owen, T.A. Popoff, S.N. (2003) Expression of connective tissue growth factor in bone: its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo. Journal of Cellular Physiology, 196, 51 61.
29. Sakai, A., Marti, G.E., Caporaso, N., Pittaluga, S., Touchman, J.W., Fend, F. Raffeld, M. (2000) Analysis of expressed immunoglobulin heavy chain genes in familial B-CLL. Blood, 95, 1413 1419.
30. Tian, E., Zhan, F., Walker, R., Rasmussen, E., Ma, Y., Barlogie, B. Shaughnessy, Jr., J.D. (2003) The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. The New England Jouranl of Medicine, 349, 2483 2494.
31. Vacca, A., Ribatti, D., Presta, M., Minischetti, M., Iurlaro, M., Ria, R., Albini, A., Bussolino, F. Dammacco, F. (1999) Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinases-2 secretion parallel progression of human multiple myeloma. Blood, 93, 3064 3073.
32. Wahlgren, J., Maisi, P., Sorsa, T., Sutinen, M., Tervahartiala, T., Pirila, E., Teronen, O., Hietanen, J., Tjaderhane, L. Salo, T. (2001) Expression and induction of collagenases (MMP-8 and -13) in plasma cells associated with bone-destructive lesions. Journal of Pathology, 194, 217 224.
33. Wenger, C., Ellenrieder, V., Alber, B., Lacher, U., Menke, A., Hameister, H., Wilda, M., Iwamura, T., Beger, H.G., Adler, G. Gress, T.M. (1999) Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Oncogene, 18, 1073 1080.